2 Top Biotech Stocks to Buy Right Now
It's been a rough year for the biotech industry, which as a whole has substantially lagged the broader market. Just look at the performance of the SPDR S&P Biotech ETF, an industry benchmark. What's more, some biotechs have been encountering their own company-specific issues.
Two worth a closer look today are Amgen (NASDAQ: AMGN) and Moderna (NASDAQ: MRNA) whose prospects really don't look as bad as their year-to-date performances suggest. At current levels, both Amgen and Moderna are worth investing in now. Let's find out why.
Source Fool.com
Amgen Inc. Stock
€300.15
0.180%
With 28 Buy predictions and not a single Sell prediction Amgen Inc. is an absolute favorite of our community.
As a result the target price of 304 € shows a slightly positive potential of 1.28% compared to the current price of 300.15 € for Amgen Inc..
